Fang Rong Chang
Kaohsiung Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fang Rong Chang.
Organic Letters | 2012
Teigo Asai; Yu-Ming Chung; Hiroaki Sakurai; Tomoji Ozeki; Fang Rong Chang; Kouwa Yamashita; Yoshiteru Oshima
The concomitant addition of the histone deacetylase inhibitor and the DNA methyltransferase inhibitor to the culture medium of an entomopathogenic fungus, Isaria tenuipes, greatly enhanced its secondary metabolite production and led to the isolation of tenuipyrone (1), a novel polyketide with an unprecedented tetracyclic ring system bearing a spiroketal structural component, along with two known C(10)-polyketides, cephalosporolide B (2), which is a plausible biosynthetic precursor of 1, and cephalosporolide F (3).
Journal of Natural Products | 2008
Yu Li Chen; Yu Hsuan Lan; Pei Wen Hsieh; Chin Chung Wu; Shu Li Chen; Chiao Ting Yen; Fang Rong Chang; Wen Chun Hung; Yang Chang Wu
Five new cembrane-type diterpenoids with a trans-fused alpha-methylene-gamma-lactone (1-5), a new flavonoid glucoside (6), and 17 known compounds were isolated from a methanol extract of Anisomeles indica. The structures of 1-6 were elucidated by spectroscopic analysis, and the absolute configuration of compound 1 was determined using the modified Moshers method. Compound 8 (4,5-epoxovatodiolide) exhibited cytotoxicity against a small panel of human cancer cell lines. Additionally, compounds 4 and 7 (ovatodiolide) exhibited selective antiplatelet aggregation activities toward collagen, while compounds 4, 5, and 8 showed inhibitory effects on antiplatelet aggregation induced by thrombin.
Bioorganic & Medicinal Chemistry Letters | 2003
Jiu Hong Wu; Fang Rong Chang; Ken-ichiro Hayashi; Hiroaki Shiraki; Chih Chuang Liaw; Yuka Nakanishi; Kenneth F. Bastow; Donglei Yu; Ih Sheng Chen; Kuo Hsiung Lee
A new inhibitor of in vitro tumor cell replication, cappamensin A (1) (2H-1,4-benzoxazin-3(4H)-one, 6-methoxy-2-methyl-4-carbaldehyde), was isolated from the roots of Capparis sikkimensis subsp. formosana using bioactivity-guided fractionation. The structure of 1 was established by spectroscopic methods, including 2D NMR analyses. Compound 1 displayed significant in vitro anticancer activity against ovarian (1A9), lung (A549), ileocecal (HCT-8), breast (MCF-7), nasopharyngeal (KB), and vincristine resistant (KB-VIN) human tumor cell lines with ED(50) values </=4 microgram/mL (mean GI(50) value of 15.1 microM).
Tetrahedron Letters | 2012
Teigo Asai; Takashi Yamamoto; Yu Ming Chung; Fang Rong Chang; Yang Chang Wu; Kouwa Yamashita; Yoshiteru Oshima
Journal of Natural Products | 2004
Ken-ichiro Hayashi; Fang Rong Chang; Yuka Nakanishi; Kenneth F. Bastow; Gordon M. Cragg; Andrew T. McPhail; Hiroshi Nozaki; Kuo Hsiung Lee
Bioorganic & Medicinal Chemistry | 2005
Chih Chuang Liaw; Fang Rong Chang; Shu Li Chen; Chin Chung Wu; Kuo Hsiung Lee; Yang Chang Wu
Planta Medica | 2012
Sf Wu; Fang Rong Chang; Yang Chang Wu; Kuo Hsiung Lee
Planta Medica | 2012
Ct Hsieh; Tusty Jiuan Hsieh; Yang Chang Wu; Fang Rong Chang
Planta Medica | 2012
Yu-Chi Tsai; Tusty Jiuan Hsieh; Mc Liao; Pj Lien; Cc Sun; Fang Rong Chang; Yang Chang Wu
Planta Medica | 2008
Chih Chuang Liaw; Yu Liang Yang; M. Chen; Fang Rong Chang; Su Li Chen; Shih-Hsiung Wu; Yang Chang Wu